{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T21:33:08Z","timestamp":1793136788818,"version":"4.5.0"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,4,11]],"date-time":"2023-04-11T00:00:00Z","timestamp":1681171200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,4,11]],"date-time":"2023-04-11T00:00:00Z","timestamp":1681171200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Doctoral Program in Molecular Medicine"},{"DOI":"10.13039\/501100012691","name":"OLVI-s\u00e4\u00e4ti\u00f6","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100012691","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100011842","name":"Finnish National Agency for Education","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100011842","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Migraine Research Foundation Impact Award"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Headache Pain"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Engaging the endocannabinoid system through inhibition of monoacylglycerol lipase (MAGL) and fatty acid amide hydrolase (FAAH), degrading endocannabinoids (endoCBs) 2-arachidonoylglycerol (2-AG) and anandamide (AEA), was proposed as a promising approach to ameliorate migraine pain. However, the activity of MAGL and FAAH and action of endoCB on spiking activity of meningeal\u00a0afferents, from which migraine pain originates, has not been explored thus far. Therefore, we here explored the analgesic effects of endoCB enhancement in rat and human meningeal tissues.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Both MAGL and FAAH activity and local 2-AG and AEA levels were measured by activity-based protein profiling (ABPP) and LC\u2013MS\/MS, respectively, in rat meninges obtained from hemiskulls of P38-P40 Wistar rats and human meninges from elderly patients undergoing non-migraine related neurosurgery. The action on endoCBs upon administration of novel dual MAGL\/FAAH inhibitor AKU-005 on meningeal afferents excitability was tested by investigating paired KCl-induced spiking and validation with local (co-)application of either AEA or 2-AG. Finally,\u00a0the specific TRPV1 agonist capsaicin and blocker capsazepine were tested.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The basal level of 2-AG exceeded that of AEA in rat and human meninges. KCl-induced depolarization doubled the level of AEA. AKU-005 slightly increased spontaneous spiking activity whereas the dual MAGL\/FAAH inhibitor significantly decreased excitation of nerve fibres induced by KCl. Similar inhibitory effects on meningeal afferents were observed with local applications of 2-AG or AEA. The action of AKU-005 was reversed by CB1 antagonist AM-251, implying CB1 receptor involvement in the anti-nociceptive effect. The inhibitory action of AEA was also reversed by AM-251, but not with the TRPV1 antagonist capsazepine. Data cluster analysis revealed that both AKU-005 and AEA largely increased long-term depression-like meningeal spiking activity upon paired KCl-induced spiking.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>In the meninges, high anti-nociceptive 2-AG levels can tonically counteract meningeal signalling, whereas AEA can be engaged on demand by local depolarization. AEA-mediated anti-nociceptive effects through CB1 receptors have therapeutic potential. Together with previously detected MAGL activity in trigeminal ganglia, dual MAGL\/FAAH inhibitor AKU-005 appears promising as migraine treatment.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Graphical Abstract<\/jats:title>\n                \n              <\/jats:sec>","DOI":"10.1186\/s10194-023-01568-3","type":"journal-article","created":{"date-parts":[[2023,4,10]],"date-time":"2023-04-10T23:02:22Z","timestamp":1681167742000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Potent dual MAGL\/FAAH inhibitor AKU-005 engages endocannabinoids to diminish meningeal nociception implicated in migraine pain"],"prefix":"10.1186","volume":"24","author":[{"given":"Adriana","family":"Della Pietra","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgii","family":"Krivoshein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantin","family":"Ivanov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raisa","family":"Giniatullina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henna-Kaisa","family":"Jyrkk\u00e4nen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ville","family":"Leinonen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marko","family":"Lehtonen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arn M. J. M.","family":"van den Maagdenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juha","family":"Savinainen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rashid","family":"Giniatullin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,4,11]]},"reference":[{"key":"1568_CR1","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1007\/s00221-009-1756-y","volume":"196","author":"K Messlinger","year":"2009","unstructured":"Messlinger K (2009) Migraine: where and how does the pain originate? Exp brain Res 196:179\u2013193. https:\/\/doi.org\/10.1007\/s00221-009-1756-y","journal-title":"Exp brain Res"},{"key":"1568_CR2","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1016\/S1474-4422(09)70090-0","volume":"8","author":"J Olesen","year":"2009","unstructured":"Olesen J, Burstein R, Ashina M, Tfelt-Hansen P (2009) Origin of pain in migraine: evidence for peripheral sensitisation. Lancet Neurol 8:679\u2013690. https:\/\/doi.org\/10.1016\/S1474-4422(09)70090-0","journal-title":"Lancet Neurol"},{"key":"1568_CR3","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1186\/s10194-019-1042-8","volume":"20","author":"H Bolay","year":"2019","unstructured":"Bolay H, Vuralli D, Goadsby PJ (2019) Aura and Head pain: relationship and gaps in the translational models. J Headache Pain 20:94. https:\/\/doi.org\/10.1186\/s10194-019-1042-8","journal-title":"J Headache Pain"},{"key":"1568_CR4","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s10194-018-0848-0","volume":"19","author":"K Messlinger","year":"2018","unstructured":"Messlinger K (2018) The big CGRP flood - sources, sinks and signalling sites in the trigeminovascular system. J Headache Pain 19:22. https:\/\/doi.org\/10.1186\/s10194-018-0848-0","journal-title":"J Headache Pain"},{"key":"1568_CR5","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1007\/s00702-020-02161-7","volume":"127","author":"K Messlinger","year":"2020","unstructured":"Messlinger K, Balcziak LK, Russo AF (2020) Cross-talk signaling in the trigeminal ganglion: role of neuropeptides and other mediators. J Neural Transm 127:431\u2013444. https:\/\/doi.org\/10.1007\/s00702-020-02161-7","journal-title":"J Neural Transm"},{"key":"1568_CR6","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1007\/s12031-020-01493-z","volume":"70","author":"L Edvinsson","year":"2020","unstructured":"Edvinsson L, Grell A-S, Warfvinge K (2020) Expression of the CGRP Family of Neuropeptides and their Receptors in the Trigeminal Ganglion. J Mol Neurosci 70:930\u2013944. https:\/\/doi.org\/10.1007\/s12031-020-01493-z","journal-title":"J Mol Neurosci"},{"key":"1568_CR7","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1177\/0333102410362122","volume":"30","author":"L Edvinsson","year":"2010","unstructured":"Edvinsson L, Chan KY, Eftekhari S et al (2010) Effect of the calcitonin gene-related peptide (CGRP) receptor antagonist telcagepant in human cranial arteries. Cephalalgia 30:1233\u20131240. https:\/\/doi.org\/10.1177\/0333102410362122","journal-title":"Cephalalgia"},{"key":"1568_CR8","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s10194-022-01399-8","volume":"23","author":"IM Christiansen","year":"2022","unstructured":"Christiansen IM, Edvinsson JCA, Reducha PV et al (2022) Dual action of the cannabinoid receptor 1 ligand arachidonyl-2\u2032-chloroethylamide on calcitonin gene-related peptide release. J Headache Pain 23:30. https:\/\/doi.org\/10.1186\/s10194-022-01399-8","journal-title":"J Headache Pain"},{"key":"1568_CR9","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1124\/jpet.105.093286","volume":"316","author":"S Maione","year":"2006","unstructured":"Maione S, Bisogno T, de Novellis V et al (2006) Elevation of endocannabinoid levels in the ventrolateral periaqueductal grey through inhibition of fatty acid amide hydrolase affects descending nociceptive pathways via both cannabinoid receptor type 1 and transient receptor potential vanilloid type-1 re. J Pharmacol Exp Ther 316:969\u2013982. https:\/\/doi.org\/10.1124\/jpet.105.093286","journal-title":"J Pharmacol Exp Ther"},{"key":"1568_CR10","first-page":"517","volume":"258","author":"AH Lichtman","year":"1991","unstructured":"Lichtman AH, Martin BR (1991) Spinal and supraspinal components of cannabinoid-induced antinociception. J Pharmacol Exp Ther 258:517\u2013523","journal-title":"J Pharmacol Exp Ther"},{"key":"1568_CR11","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/S0304-3959(98)00041-4","volume":"76","author":"SI Jaggar","year":"1998","unstructured":"Jaggar SI, Hasnie FS, Sellaturay S, Rice AS (1998) The anti-hyperalgesic actions of the cannabinoid anandamide and the putative CB2 receptor agonist palmitoylethanolamide in visceral and somatic inflammatory pain. Pain 76:189\u2013199. https:\/\/doi.org\/10.1016\/S0304-3959(98)00041-4","journal-title":"Pain"},{"key":"1568_CR12","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1097\/00000542-200103000-00023","volume":"94","author":"WP Farquhar-Smith","year":"2001","unstructured":"Farquhar-Smith WP, Rice ASC (2001) Administration of Endocannabinoids Prevents a Referred Hyperalgesia Associated with Inflammation of the Urinary Bladder. Anesthesiology 94:507\u2013513. https:\/\/doi.org\/10.1097\/00000542-200103000-00023","journal-title":"Anesthesiology"},{"key":"1568_CR13","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1038\/346561a0","volume":"346","author":"LA Matsuda","year":"1990","unstructured":"Matsuda LA, Lolait SJ, Brownstein MJ et al (1990) Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature 346:561\u2013564. https:\/\/doi.org\/10.1038\/346561a0","journal-title":"Nature"},{"key":"1568_CR14","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1038\/365061a0","volume":"365","author":"S Munro","year":"1993","unstructured":"Munro S, Thomas KL, Abu-Shaar M (1993) Molecular characterization of a peripheral receptor for cannabinoids. Nature 365:61\u201365. https:\/\/doi.org\/10.1038\/365061a0","journal-title":"Nature"},{"key":"1568_CR15","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/0006-2952(95)00109-d","volume":"50","author":"R Mechoulam","year":"1995","unstructured":"Mechoulam R, Ben-Shabat S, Hanus L et al (1995) Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors. Biochem Pharmacol 50:83\u201390. https:\/\/doi.org\/10.1016\/0006-2952(95)00109-d","journal-title":"Biochem Pharmacol"},{"key":"1568_CR16","doi-asserted-by":"publisher","first-page":"1746","DOI":"10.1016\/j.neuropharm.2011.11.021","volume":"62","author":"K Starowicz","year":"2012","unstructured":"Starowicz K, Makuch W, Osikowicz M et al (2012) Spinal anandamide produces analgesia in neuropathic rats: possible CB(1)- and TRPV1-mediated mechanisms. Neuropharmacology 62:1746\u20131755. https:\/\/doi.org\/10.1016\/j.neuropharm.2011.11.021","journal-title":"Neuropharmacology"},{"key":"1568_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fphar.2018.00420","volume":"9","author":"P Leimuranta","year":"2018","unstructured":"Leimuranta P, Khiroug L, Giniatullin R (2018) Emerging role of (endo)cannabinoids in migraine. Front Pharmacol 9:1\u20137. https:\/\/doi.org\/10.3389\/fphar.2018.00420","journal-title":"Front Pharmacol"},{"key":"1568_CR18","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1097\/WCO.0000000000000688","volume":"32","author":"C Tassorelli","year":"2019","unstructured":"Tassorelli C, Greco R, Silberstein SD (2019) The endocannabinoid system in migraine: from bench to pharmacy and back. Curr Opin Neurol 32:405\u2013412. https:\/\/doi.org\/10.1097\/WCO.0000000000000688","journal-title":"Curr Opin Neurol"},{"key":"1568_CR19","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/j.chembiol.2013.01.012","volume":"20","author":"N Aaltonen","year":"2013","unstructured":"Aaltonen N, Savinainen JR, Ribas CR et al (2013) Piperazine and Piperidine Triazole Ureas as Ultrapotent and Highly Selective Inhibitors of Monoacylglycerol Lipase. Chem Biol 20:379\u2013390. https:\/\/doi.org\/10.1016\/j.chembiol.2013.01.012","journal-title":"Chem Biol"},{"key":"1568_CR20","doi-asserted-by":"publisher","unstructured":"Della Pietra A, Giniatullin R, Savinainen JR (2021) Distinct Activity of Endocannabinoid-Hydrolyzing Enzymes MAGL and FAAH in Key Regions of Peripheral and Central Nervous System Implicated in Migraine. Int J Mol Sci 22:1204. https:\/\/doi.org\/10.3390\/ijms22031204","DOI":"10.3390\/ijms22031204"},{"key":"1568_CR21","doi-asserted-by":"publisher","first-page":"1661","DOI":"10.1177\/0333102418786261","volume":"39","author":"K Messlinger","year":"2019","unstructured":"Messlinger K, Russo AF (2019) Current understanding of trigeminal ganglion structure and function in headache. Cephalalgia 39:1661\u20131674. https:\/\/doi.org\/10.1177\/0333102418786261","journal-title":"Cephalalgia"},{"key":"1568_CR22","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1111\/head.12371","volume":"54","author":"M Schueler","year":"2014","unstructured":"Schueler M, Neuhuber WL, De Col R, Messlinger K (2014) Innervation of Rat and Human Dura Mater and Pericranial Tissues in the Parieto-Temporal Region by Meningeal Afferents. Headache J Head Face Pain 54:996\u20131009. https:\/\/doi.org\/10.1111\/head.12371","journal-title":"Headache J Head Face Pain"},{"key":"1568_CR23","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1093\/brain\/awy005","volume":"141","author":"D Fontaine","year":"2018","unstructured":"Fontaine D, Almairac F, Santucci S et al (2018) Dural and pial pain-sensitive structures in humans: new inputs from awake craniotomies. Brain 141:1040\u20131048. https:\/\/doi.org\/10.1093\/brain\/awy005","journal-title":"Brain"},{"key":"1568_CR24","doi-asserted-by":"publisher","unstructured":"Eren-Ko\u00e7ak E, Dalkara T (2021) Ion Channel Dysfunction and Neuroinflammation in Migraine and Depression . Front Pharmacol 12:777607. https:\/\/doi.org\/10.3389\/fphar.2021.777607","DOI":"10.3389\/fphar.2021.777607"},{"key":"1568_CR25","doi-asserted-by":"publisher","unstructured":"Zhao J, Levy D (2018) The CGRP receptor antagonist BIBN4096 inhibits prolonged meningeal afferent activation evoked by brief local K+ stimulation but not cortical spreading depression-induced afferent sensitization. PAIN Reports 3:e632. https:\/\/doi.org\/10.1097\/PR9.0000000000000632","DOI":"10.1097\/PR9.0000000000000632"},{"key":"1568_CR26","doi-asserted-by":"publisher","first-page":"1606","DOI":"10.1177\/0333102418771350","volume":"39","author":"D Levy","year":"2019","unstructured":"Levy D, Labastida-Ramirez A, MaassenVanDenBrink A (2019) Current understanding of meningeal and cerebral vascular function underlying migraine headache. Cephalalgia 39:1606\u20131622. https:\/\/doi.org\/10.1177\/0333102418771350","journal-title":"Cephalalgia"},{"key":"1568_CR27","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.ejps.2016.08.031","volume":"93","author":"D Navia-Paldanius","year":"2016","unstructured":"Navia-Paldanius D, Patel JZ, L\u00f3pez Navarro M et al (2016) Chemoproteomic, biochemical and pharmacological approaches in the discovery of inhibitors targeting human \u03b1\/\u03b2-hydrolase domain containing 11 (ABHD11). Eur J Pharm Sci 93:253\u2013263. https:\/\/doi.org\/10.1016\/j.ejps.2016.08.031","journal-title":"Eur J Pharm Sci"},{"key":"1568_CR28","doi-asserted-by":"publisher","first-page":"2413","DOI":"10.1194\/jlr.M030411","volume":"53","author":"D Navia-Paldanius","year":"2012","unstructured":"Navia-Paldanius D, Savinainen JR, Laitinen JT (2012) Biochemical and pharmacological characterization of human \u03b1\/\u03b2-hydrolase domain containing 6 (ABHD6) and 12 (ABHD12). J Lipid Res 53:2413\u20132424. https:\/\/doi.org\/10.1194\/jlr.M030411","journal-title":"J Lipid Res"},{"key":"1568_CR29","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1016\/j.jchromb.2011.02.004","volume":"879","author":"M Lehtonen","year":"2011","unstructured":"Lehtonen M, Storvik M, Malinen H et al (2011) Determination of endocannabinoids in nematodes and human brain tissue by liquid chromatography electrospray ionization tandem mass spectrometry. J Chromatogr B 879:677\u2013694. https:\/\/doi.org\/10.1016\/j.jchromb.2011.02.004","journal-title":"J Chromatogr B"},{"key":"1568_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fncel.2015.00287","volume":"9","author":"A Zakharov","year":"2015","unstructured":"Zakharov A, Vitale C, Kilinc E et al (2015) Hunting for origins of migraine pain\u202f: cluster analysis of spontaneous and capsaicin-induced firing in meningeal trigeminal nerve fibers. Front Cell Neurosci 9:1\u201314. https:\/\/doi.org\/10.3389\/fncel.2015.00287","journal-title":"Front Cell Neurosci"},{"key":"1568_CR31","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1113\/jphysiol.2011.220624","volume":"590","author":"R De Col","year":"2012","unstructured":"De Col R, Messlinger K, Carr RW (2012) Repetitive activity slows axonal conduction velocity and concomitantly increases mechanical activation threshold in single axons of the rat cranial dura. J Physiol 590:725\u2013736. https:\/\/doi.org\/10.1113\/jphysiol.2011.220624","journal-title":"J Physiol"},{"key":"1568_CR32","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1007\/s12668-017-0428-9","volume":"7","author":"O Gafurov","year":"2017","unstructured":"Gafurov O, Zakharov A, Koroleva K, Giniatullin R (2017) Improvement of Nociceptive Spike Clusterization with Shape Approximation. Bionanoscience 7:565\u2013569. https:\/\/doi.org\/10.1007\/s12668-017-0428-9","journal-title":"Bionanoscience"},{"key":"1568_CR33","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1007\/s12668-016-0276-z","volume":"6","author":"A Zakharov","year":"2016","unstructured":"Zakharov A, Koroleva K, Giniatullin R (2016) Clustering Analysis for Sorting ATP-Induced Nociceptive Firing in rat Meninges. Bionanoscience 6:508\u2013512. https:\/\/doi.org\/10.1007\/s12668-016-0276-z","journal-title":"Bionanoscience"},{"key":"1568_CR34","doi-asserted-by":"publisher","first-page":"2379","DOI":"10.1162\/NECO_a_00661","volume":"26","author":"SN Kadir","year":"2014","unstructured":"Kadir SN, Goodman DFM, Harris KD (2014) High-Dimensional Cluster Analysis with the Masked EM Algorithm. Neural Comput 26:2379\u20132394. https:\/\/doi.org\/10.1162\/NECO_a_00661","journal-title":"Neural Comput"},{"key":"1568_CR35","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1111\/j.1748-1716.2011.02280.x","volume":"204","author":"JR Savinainen","year":"2012","unstructured":"Savinainen JR, Saario SM, Laitinen JT (2012) The serine hydrolases MAGL, ABHD6 and ABHD12 as guardians of 2-arachidonoylglycerol signalling through cannabinoid receptors. Acta Physiol 204:267\u2013276. https:\/\/doi.org\/10.1111\/j.1748-1716.2011.02280.x","journal-title":"Acta Physiol"},{"key":"1568_CR36","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/j.intimp.2018.09.006","volume":"64","author":"SL Cruz","year":"2018","unstructured":"Cruz SL, S\u00e1nchez-Miranda E, Castillo-Arellano JI et al (2018) Anandamide inhibits Fc\u03b5RI-dependent degranulation and cytokine synthesis in mast cells through CB2 and GPR55 receptor activation. Possible involvement of CB2-GPR55 heteromers. Int Immunopharmacol 64:298\u2013307. https:\/\/doi.org\/10.1016\/j.intimp.2018.09.006","journal-title":"Int Immunopharmacol"},{"key":"1568_CR37","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1038\/nrn4036","volume":"16","author":"B Lutz","year":"2015","unstructured":"Lutz B, Marsicano G, Maldonado R, Hillard CJ (2015) The endocannabinoid system in guarding against fear, anxiety and stress. Nat Rev Neurosci 16:705\u2013718. https:\/\/doi.org\/10.1038\/nrn4036","journal-title":"Nat Rev Neurosci"},{"key":"1568_CR38","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1189\/jlb.0405216","volume":"78","author":"GA Cabral","year":"2005","unstructured":"Cabral GA, Marciano-Cabral F (2005) Cannabinoid receptors in microglia of the central nervous system: immune functional relevance. J Leukoc Biol 78:1192\u20131197","journal-title":"J Leukoc Biol"},{"key":"1568_CR39","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1124\/jpet.115.222851","volume":"354","author":"S Ghosh","year":"2015","unstructured":"Ghosh S, Kinsey SG, Liu Q-S et al (2015) Full Fatty Acid Amide Hydrolase Inhibition Combined with Partial Monoacylglycerol Lipase Inhibition: Augmented and Sustained Antinociceptive Effects with Reduced Cannabimimetic Side Effects in Mice. J Pharmacol Exp Ther 354:111\u2013120. https:\/\/doi.org\/10.1124\/jpet.115.222851","journal-title":"J Pharmacol Exp Ther"},{"key":"1568_CR40","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1111\/ejn.14897","volume":"55","author":"E Kilinc","year":"2022","unstructured":"Kilinc E, Ankarali S, Torun IE, Dagistan Y (2022) Receptor mechanisms mediating the anti-neuroinflammatory effects of endocannabinoid system modulation in a rat model of migraine. Eur J Neurosci 55:1015\u20131031. https:\/\/doi.org\/10.1111\/ejn.14897","journal-title":"Eur J Neurosci"},{"key":"1568_CR41","doi-asserted-by":"publisher","unstructured":"Koroleva K, Gafurov O, Guselnikova V, et al (2019) Meningeal Mast Cells Contribute to ATP-Induced Nociceptive Firing in Trigeminal Nerve Terminals: Direct and Indirect Purinergic Mechanisms Triggering Migraine Pain. Front Cell Neurosci 13:. https:\/\/doi.org\/10.3389\/fncel.2019.00195","DOI":"10.3389\/fncel.2019.00195"},{"key":"1568_CR42","doi-asserted-by":"publisher","unstructured":"Greco R, Demartini C, Zanaboni A, et al (2021) Characterization of the peripheral FAAH inhibitor, URB937, in animal models of acute and chronic migraine. Neurobiol Dis 147:105157. https:\/\/doi.org\/10.1016\/j.nbd.2020.105157","DOI":"10.1016\/j.nbd.2020.105157"},{"key":"1568_CR43","doi-asserted-by":"publisher","unstructured":"Greco R, Bandiera T, Mangione A, et al (2015) Effects of peripheral FAAH blockade on NTG-induced hyperalgesia\u2014evaluation of URB937 in an animal model of migraine. Cephalalgia 35:1065\u20131076. https:\/\/doi.org\/10.1177\/0333102414566862","DOI":"10.1177\/0333102414566862"},{"key":"1568_CR44","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1038\/sj.bjp.0706699","volume":"148","author":"L Chang","year":"2006","unstructured":"Chang L, Luo L, Palmer JA et al (2006) Inhibition of fatty acid amide hydrolase produces analgesia by multiple mechanisms. Br J Pharmacol 148:102\u2013113. https:\/\/doi.org\/10.1038\/sj.bjp.0706699","journal-title":"Br J Pharmacol"},{"key":"1568_CR45","doi-asserted-by":"publisher","first-page":"4407","DOI":"10.3390\/ijms23084407","volume":"23","author":"A Della Pietra","year":"2022","unstructured":"Della Pietra A, Savinainen J, Giniatullin R (2022) Inhibiting Endocannabinoid Hydrolysis as Emerging Analgesic Strategy Targeting a Spectrum of Ion Channels Implicated in Migraine Pain. Int J Mol Sci 23:4407. https:\/\/doi.org\/10.3390\/ijms23084407","journal-title":"Int J Mol Sci"},{"key":"1568_CR46","doi-asserted-by":"publisher","unstructured":"Piomelli D, Tagne AM (2022) Endocannabinoid-Based Therapies. Annu Rev Pharmacol Toxicol 62:. https:\/\/doi.org\/10.1146\/annurev-pharmtox-052220-021800","DOI":"10.1146\/annurev-pharmtox-052220-021800"},{"key":"1568_CR47","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1111\/bph.13337","volume":"173","author":"NS Adamson Barnes","year":"2016","unstructured":"Adamson Barnes NS, Mitchell VA, Kazantzis NP, Vaughan CW (2016) Actions of the dual FAAH\/MAGL inhibitor JZL195 in a murine neuropathic pain model. Br J Pharmacol 173:77\u201387. https:\/\/doi.org\/10.1111\/bph.13337","journal-title":"Br J Pharmacol"},{"key":"1568_CR48","doi-asserted-by":"publisher","first-page":"2543","DOI":"10.3390\/cells10102543","volume":"10","author":"R Greco","year":"2021","unstructured":"Greco R, Demartini C, Francavilla M et al (2021) Dual Inhibition of FAAH and MAGL Counteracts Migraine-like Pain and Behavior in an Animal Model of Migraine. Cells 10:2543. https:\/\/doi.org\/10.3390\/cells10102543","journal-title":"Cells"},{"key":"1568_CR49","doi-asserted-by":"publisher","first-page":"471","DOI":"10.3390\/cells11030471","volume":"11","author":"A Papa","year":"2022","unstructured":"Papa A, Pasquini S, Contri C et al (2022) Polypharmacological Approaches for CNS Diseases: Focus on Endocannabinoid Degradation Inhibition. Cells 11:471. https:\/\/doi.org\/10.3390\/cells11030471","journal-title":"Cells"},{"key":"1568_CR50","doi-asserted-by":"publisher","first-page":"20270","DOI":"10.1073\/pnas.0909411106","volume":"106","author":"JZ Long","year":"2009","unstructured":"Long JZ, Nomura DK, Vann RE et al (2009) Dual blockade of FAAH and MAGL identifies behavioral processes regulated by endocannabinoid crosstalk in vivo. Proc Natl Acad Sci 106:20270\u201320275. https:\/\/doi.org\/10.1073\/pnas.0909411106","journal-title":"Proc Natl Acad Sci"},{"key":"1568_CR51","doi-asserted-by":"publisher","first-page":"3570","DOI":"10.1111\/j.1460-9568.2007.05582.x","volume":"25","author":"MJM Fischer","year":"2007","unstructured":"Fischer MJM, Reeh PW (2007) Sensitization to heat through G-protein-coupled receptor pathways in the isolated sciatic mouse nerve. Eur J Neurosci 25:3570\u20133575. https:\/\/doi.org\/10.1111\/j.1460-9568.2007.05582.x","journal-title":"Eur J Neurosci"},{"key":"1568_CR52","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1016\/j.neuroscience.2004.03.017","volume":"126","author":"N Bernardini","year":"2004","unstructured":"Bernardini N, Neuhuber W, Reeh P, Sauer S (2004) Morphological evidence for functional capsaicin receptor expression and calcitonin gene-related peptide exocytosis in isolated peripheral nerve axons of the mouse. Neuroscience 126:585\u2013590. https:\/\/doi.org\/10.1016\/j.neuroscience.2004.03.017","journal-title":"Neuroscience"},{"key":"1568_CR53","doi-asserted-by":"publisher","unstructured":"Gafurov O, Koroleva K, Giniatullin R (2021) Antidromic Spike Propagation and Dissimilar Expression of P2X, 5-HT, and TRPV1 Channels in Peripheral vs. Central Sensory Axons in Meninges. Front Cell Neurosci 14:. https:\/\/doi.org\/10.3389\/fncel.2020.623134","DOI":"10.3389\/fncel.2020.623134"},{"key":"1568_CR54","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1186\/s10194-019-1055-3","volume":"20","author":"JCA Edvinsson","year":"2019","unstructured":"Edvinsson JCA, Warfvinge K, Krause DN et al (2019) C-fibers may modulate adjacent A\u03b4-fibers through axon-axon CGRP signaling at nodes of Ranvier in the trigeminal system. J Headache Pain 20:105. https:\/\/doi.org\/10.1186\/s10194-019-1055-3","journal-title":"J Headache Pain"},{"key":"1568_CR55","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/S1471-4892(01)00120-5","volume":"2","author":"L Iversen","year":"2002","unstructured":"Iversen L (2002) Cannabinoids: a real prospect for pain relief. Curr Opin Pharmacol 2:50\u201355. https:\/\/doi.org\/10.1016\/S1471-4892(01)00120-5","journal-title":"Curr Opin Pharmacol"},{"key":"1568_CR56","doi-asserted-by":"publisher","first-page":"S13","DOI":"10.1038\/sj.ijo.0803272","volume":"30","author":"RG Pertwee","year":"2006","unstructured":"Pertwee RG (2006) The pharmacology of cannabinoid receptors and their ligands: An overview. Int J Obes 30:S13\u2013S18. https:\/\/doi.org\/10.1038\/sj.ijo.0803272","journal-title":"Int J Obes"},{"key":"1568_CR57","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/s10194-016-0644-7","volume":"17","author":"M Dux","year":"2016","unstructured":"Dux M, De\u00e1k \u00c9, Tassi N et al (2016) Endovanilloids are potential activators of the trigeminovascular nocisensor complex. J Headache Pain 17:53. https:\/\/doi.org\/10.1186\/s10194-016-0644-7","journal-title":"J Headache Pain"},{"key":"1568_CR58","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1124\/jpet.103.059808","volume":"309","author":"S Akerman","year":"2004","unstructured":"Akerman S, Kaube H, Goadsby PJ (2004) Anandamide Is Able to Inhibit Trigeminal Neurons Using an in Vivo Model of Trigeminovascular-Mediated Nociception. J Pharmacol Exp Ther 309:56\u201363. https:\/\/doi.org\/10.1124\/jpet.103.059808","journal-title":"J Pharmacol Exp Ther"},{"key":"1568_CR59","doi-asserted-by":"publisher","unstructured":"Muller C, Lynch DL, Hurst DP, Reggio PH (2020) A Closer Look at Anandamide Interaction With TRPV1. Front Mol Biosci 7:. https:\/\/doi.org\/10.3389\/fmolb.2020.00144","DOI":"10.3389\/fmolb.2020.00144"}],"container-title":["The Journal of Headache and Pain"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s10194-023-01568-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s10194-023-01568-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s10194-023-01568-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,10]],"date-time":"2023-04-10T23:02:33Z","timestamp":1681167753000},"score":1,"resource":{"primary":{"URL":"https:\/\/thejournalofheadacheandpain.biomedcentral.com\/articles\/10.1186\/s10194-023-01568-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,11]]},"references-count":59,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["1568"],"URL":"https:\/\/doi.org\/10.1186\/s10194-023-01568-3","relation":{},"ISSN":["1129-2377"],"issn-type":[{"value":"1129-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,11]]},"assertion":[{"value":"31 January 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 March 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 April 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All experimental procedures performed in this study follow the rules of the European Community Council Directive of September 22, 2010 (2010\/63\/EEC). The Animal Care and Use Committee of the University of Eastern Finland (licence EKS-008\u20132019) approved all experimental protocols.Human samples were collected according to a favourable opinion of the Research Ethics Committee, Hospital District of Northern Savo (164\/2016, 22.6.2021). Written informed consent was obtained from all patients before the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Included in written consent.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"38"}}